Aristo Bio-Tech And Lifescience Ltd.
NSE: ARISTO
₹115.90
₹0.00 (0.00%)As on 15-May-2026 14:47IST
Market cap
₹79 Cr
Revenue (TTM)
₹318 Cr
P/E Ratio
19.4
P/B Ratio
2.1
Div. Yield
0.4 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹4 Cr
-
ROE
11.5 %
-
ROCE
13 %
-
Industry P/E
27.83
-
EV/EBITDA
10
-
Debt to Equity
0.6
-
Book Value
₹54.8
-
EPS
₹6
-
Face value
10
-
Shares outstanding
6,807,800
7 Years Aggregate
CFO
₹33.45 Cr
EBITDA
₹47.25 Cr
Net Profit
₹17.87 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Aristo Bio-Tech
| -3.4 | 35.2 | 27.7 | -8.0 | 24.0 | -- | -- |
|
BSE Commodities
| 8.0 | 6.1 | 4.5 | 15.4 | 18.1 | 11.8 | 16.4 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
Aristo Bio-Tech
| -9.8 | 104.0 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Commodities
| 12.5 | 8.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Aristo Bio-Tech
|
115.9 | 78.9 | 318.1 | 4.1 | -- | 11.5 | 19.4 | 2.1 |
| 4,349.8 | 19,550.9 | 5,620.6 | 670.4 | 13.4 | 22.4 | 29.2 | 6.1 | |
| 249.1 | 3,202.8 | 500.5 | 13.2 | 5.5 | 1.9 | 242.4 | 4.6 | |
| 1,380.1 | 2,302.9 | 1,240.4 | 132.3 | 13.1 | 12.2 | 17.4 | 1.9 | |
| 1,083.5 | 4,874.3 | 1,978.5 | 265.0 | 16.3 | 18 | 18.4 | 3.1 | |
| 722.8 | 2,096.6 | 2,072.7 | 140.8 | 9.5 | 12.4 | 14.8 | 1.7 | |
| 161.6 | 3,793.6 | 1,584.5 | 4.7 | 4.5 | 2 | 830.1 | 5.6 | |
| 263.7 | 5,133.0 | 2,897.0 | 184.0 | 8.4 | 12.1 | 27.9 | 2.5 | |
| 969.0 | 8,752.3 | 5,267.6 | 681.0 | 12.9 | 23.4 | 12.9 | 2.8 | |
| 458.8 | 22,870.9 | 3,234.0 | 531.4 | 18.3 | 17.8 | 43 | 7.0 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Aristo Bio-Tech
Manufacture of insecticides, rodenticides, fungicides, herbicides
-
Incorporated
2005
-
Chairman
Narendra Singh Barhat
-
Managing Director
Narendra Singh Barhat
-
Headquarters
Vadodara Dist, Gujarat
-
Website
Looking for more details about Aristo Bio-Tech And Lifescience Ltd.’s IPO? Explore our IPO Details page.
FAQs for Aristo Bio-Tech
What is the current share price of Aristo Bio-Tech And Lifescience Ltd Today?
The share price of Aristo Bio-Tech And Lifescience Ltd is ₹115.90 (NSE) as of 15-May-2026 14:47 IST. Aristo Bio-Tech And Lifescience Ltd has given a return of 24.03% in the last 3 years.
What is the current PB & PE ratio of Aristo Bio-Tech And Lifescience Ltd?
The P/E ratio of Aristo Bio-Tech And Lifescience Ltd is 19.42 times as on 13-May-2026, a 30 discount to its peers’ median range of 27.83 times.
The P/B ratio of Aristo Bio-Tech And Lifescience Ltd is 2.11 times as on 13-May-2026, a 27 discount to its peers’ median range of 2.91 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
19.47
|
2.12
|
|
2024
|
10.91
|
1.27
|
|
2023
|
10.71
|
1.27
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Aristo Bio-Tech And Lifescience Ltd?
The 52-week high and low of Aristo Bio-Tech And Lifescience Ltd are Rs 143.55 and Rs 0.00 as of 17-May-2026.
What is the market cap of Aristo Bio-Tech And Lifescience Ltd?
Aristo Bio-Tech And Lifescience Ltd has a market capitalisation of ₹ 79 Cr as on 13-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Aristo Bio-Tech And Lifescience Ltd?
Before investing in Aristo Bio-Tech And Lifescience Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.